Objective To explore the relation between the blood glucose and the clinical aspects of acute bischemic stroke.Methods 164 patients with acute cerebral infarction were divided into threegroups:normal glycemic group,diabetes hyperglycemic group and non-diabetes hyperglycemic group.To study the relation between blood glucose and clinical aspects of bischemic stroke.Results There were significant differences in curatio improvement rate among the three groups(P

OBJECTIVE:To improve the classified drug control level and drug supervision in China by drawing advanced experiences from Germany.METHODS:The laws and regulations,standards for classified drug control in Germany were introduced.RESULTS & CONCLUSIONS:The humanized management,the management model on narcotic drugs,adopting advanced equipment and informationized management in Germany serve as a model for China to follow.

AIM: To study the expression of endostatin in ischemic myocardium of myocardial infarction(MI) rats in various periods and the correlation with VEGF expression and microvascular density(MVD).METHODS: Thirty-two male Sprague-Dawley rats after myocardial infarction were randomly divided into 7,14,21 and 28 days group.The sham group was normal control group(eight rats in each group).The expression of endostatin,VEGF and MVD in ischemic myocardium were observed by immunohistochemistry.RESULTS: The expression of endostatin significantly increased in the ischemic myocardium after MI,peaked at 7 days,then gradually decreased at 14,21 and 28 days.The endostatin level at 28 days was the same as the shams.The changing trends of expression of endostatin in ischemic myocardium after MI were similar to that of VEGF and were significantly correlated with the MVD.CONCLUSION: The expression of endostatin increased in ischemic myocardium of myocardial infarction rats.The changing trends of endostatin were similar to that of VEGF and positively correlated with the MVD.These data suggest that endostatin may modulate ischemic myocardium angiogenesis after myocardial infarction.

To investigate the influence of Bufei Jianpi Granule (BJG) on immune function in mice. Spleen cellular proliferation and the activities of IL-1 and IL-2 in mice were observed. The differences of spleen cellular proliferation stimulating by Con A, the secretion of IL-2 from spleen cells and the secretion of IL-1 from celiac macrophage were significant among BJG group, the control group and the water-drinking group. [Conclusion] BJG can promote the function of cellular immune and the secretion of IL-1 and IL-2 from immune active cells in mice.

Objective To summarize the clinical experience of nasal endoscopic treatment for refractory epistaxis. Methods .A retrospective analysis was made on 258 patients with refractory epistaxis treated with intranasal endoscopic exploration and hemostatic treatment from January 1998 to December 2004 in this hospital. Results .Hemorrhage was found on the nasal septum and the lateral nasal wall in 118 and 47 patients, respectively. Nose bleeding resulted from intranasal tumor in 8 patients. The site of bleeding was not clearly identified in 85 patients. Of the 258 patients, 257 responded to the treatment (99.6%) and 1 died ( 0.4%).Recurrent bleeding occurred in 43 patients. The incidence of recurrent bleeding was significantly higher in patients with unknown bleeding sites than in clearly diagnosed patients (?2=17.689,P=0.000). Conclusions .The emphasis of nasal endoscopic treatment for refractory epistaxis should be laid on the initial management, during which the bleeding site should be carefully identified. For patients with repeated nose bleeding, a combination treatment, including endoscopic filling-up of the anterior nasal cavity, endoscopic embolization of anterior and posterior nose, or embolization of the internal maxillary artery, is necessary.

Objective To construct an effective expression system for secretory canstatin, and to study its biological effects. Methods Canstatin cDNA was ligated with the cDNA of CEA signal peptide by SOE PCR, and the new fused fragment was cloned into eukaryotic expression vector pCMV-Script. The recombination vector pCMV-CEAS-Cans was transferred into human umbilical vein endothelial cells (HUV-EC) and human lung adeno-carcinoma cell line A549 by cationic liposome. The expression of canstatin mRNA together with CEAS mRNA in the transformed cells were detected by real time PCR method. Results Canstatin mRNA was detected in both transformed cells. The 3 H-TdR intake rate in pCMV-CEAS-Cans transformed HUVEC cells is significant lower than that of the pCMV-Script transformed cells (P

Purpose:To study the biological effects of high secreted canstatin on human umbilical vein endothelial cells (HUVEC) and tumor model. Methods:Hypoxic responsive elements (HREs) were inserted in the upper stream of canstatin cDNA of a recombinant vector we constructed in a former research. The new recombinant vector named pCMV-3HRE-CEAS-Cans was transferred into A549 cells by cationic liposome; canstatin mRNA expression in the transformed cells under oxic and anoxic condition was detected by Taqman PCR. Then we designed a co-cultured assay: HUVECs were co-cultured with recombinant vector transformed A549 cells with Transwell plates, and the proliferation and apoptosis of co-cultured HUVECs were evaluated with 3H-thymidine incorporation method, TUNEL method respectively. Finally the vector was introduced into tumor tissues of lung cancer-bearing nude mice, and the biological activity in the tumor tissues was tested by micro-vessel count (MVC). A vector of canstatin we constructed before was used as controls in above experiments.Results:The pCMV-3HRE-CEAS-Cans vector was successfully constructed and transferred into A549 cells. canstatin mRNA was detected both in the recombinant vector transformed A549 cells and the pCMV-CEAS-Cans transformed A549 cells, moreover the expression of canstatin in the new vector transformed A549 was significantly higher than that of the controls under hypoxic condition. ~(3)H-TdR intake rate of HUVECs was decreased markedly, and a large amount of them underwent apoptosis when they were co-cultured with recombinant vector transformed A549 cells. Significant differences of ~(3)H-TdR intake rate and apoptotic rate of co-cultured HUVEC were found between pCMV-3HRE-CEAS-Cans group and any of the controls (P

OBJECTIVE: To analyze status quo of utilization of liver-protective medicines in our hospital. METHODS: Consumption sum and DDDs of liver-protective medicines were analyzed statistically in our hospital during 2004～2008. RESULTS: The proportion of consumption sum of liver-protective medicines in total was 21.09%. The main medicines was inosine to prevent antituberculosis drug-induced hepatic lesion during 2004～2005. The utilization of new and expensive liver-protective medicines was used more than before during 2006～2008. The consumption sum was increased greatly. CONCLUSION: The utilization of liver-protective medicines is rational and economical in the previous two years. But the price of used liver-protective medicines is higher than before during 2006～2008. So some interventions should be adopted to control the utilization of liver-protective medicines rationally and economically.

0 05), only T 8 level decreased significantly in group Ⅲ (P

Objective To realize compliance actuality, discuss effect factor and institute correspond countermeasure for diabete integration treatment. Method Investigate 251 patients with diabete who did colligate treatment and community with correlation factor. Results The rate of mostly complication of diabetes was higher (66.53%), and the rate of colligate treatment was lower (only 29.08%). The compliance of treatment had relation with the rate of knowing diabete, symptom and complication, economy factors, medicine insurance, and lever of doctor closely. Conclusion We should intensify diabetes knowledge education, increase medical treatment specialty level, associate with community intervene, supervise and direction, establish consummate medical treatment insurance system to increase colligate treatment of diabetes sufferer.